Status of Epstein-Barr Virus Coinfection with

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

1. Association of Helicobacter pylori and Epstein-Barr virus co-infection in gastric cancer patients: a prospective analytical study.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2026
   Article
2. The microbiome-EBV axis in carcinogenesis bridges commensal influence and viral oncogenesis.Frontiers in immunology · 2026
   Review
3. The research progress of the synergistic effect of Epstein-Barr virus andFrontiers in oncology · 2026
   Review
4. Spatial-Temporal Trends of Cancer Among Women in Central Serbia, 1999-2021: Implications for Disaster and Public Health Preparedness.Healthcare (Basel, Switzerland) · 2025
   Article
5. Distribution and Clinical Impact ofAntibiotics (Basel, Switzerland) · 2025
   Article
6. Age-Related Differences in Gastric Adenocarcinoma from 2000-2020: A SEER Database Analysis.Journal of gastrointestinal cancer · 2025
   Article
7. Current Approaches to the Management of Postoperative Fistulas in Gastric Cancer Surgery: Experience of a Tertiary Center.Journal of clinical medicine · 2025
   Article
8. Therapeutic opportunities in EBV-positive gastric cancer subtypes.Therapeutic advances in medical oncology · 2025
   Review
9. Epstein-Barr Virus and gastric carcinoma pathogenesis with emphasis on underlying epigenetic mechanisms.Discover oncology · 2024
   Review
10. Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review.Pathogens (Basel, Switzerland) · 2024
    Review
11. Discovery of the Natural Bibenzyl Compound Erianin in Dendrobium Inhibiting the Growth and EMT of Gastric Cancer through Downregulating the LKB1-SIK2/3-PARD3 Pathway.International journal of molecular sciences · 2024
    Article
12. Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents.Pathogens and disease · 2024
    Review
13. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape.Frontiers in immunology · 2024
    Review
14. Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections.Cancers · 2023
    Review
15. Heliyon · 2023
    Review
16. Multiple Epstein-Barr Virus-associated Gastric Cancers Arising in a Patient with Autoimmune Gastritis.Internal medicine (Tokyo, Japan) · 2023
    Article
17. Updates on global epidemiology, risk and prognostic factors of gastric cancer.World journal of gastroenterology · 2023
    Review
18. Clinical Relevance ofGut and liver · 2023
    Article
19. Clinical Significance of Epstein-Barr Virus andGut and liver · 2023
    Article
20. The role of microbiota in the development and treatment of gastric cancer.Frontiers in oncology · 2023
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract